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ABSTRACT
We report a rapid technique, based on the
polymerase chain reaction (PCR), for the direct targeting,
enhancement, and sequencing of previously uncharacterized
cDNAs. This method is not limited to previously sequenced
transcripts, since it requires only two adjacent or partially
overlappingspecific primersfrom only one side of the region to
be amplif"aed.
Theseprimerscan be locatedanywherewithinthe
message. The specific primers are used in conjunction with
nonspecific primers targeted either to the poly(A)+ region of
the message or to an enzymatically synthesi7.ed
d(A) tail.
Pairwise combinations of specif'acand general primers allow for
the amplification of regions both 3' and 5' to the point of entry
into the message. The amplified PCR products can be cloned,
sequenced directly by genomic sequencing, or labeled for
sequencing by amplifying with a radioactive primer. We illustrate the power of this approach by deriving the cDNA sequences for the skeletal muscle a-tropomyosins of European
common frog (Rana temporaria) and r.ebrafish (Brachydanio
rerio) using only 300 ng of a total poly(A) + preparation. In these
examples, we gained initial entry into the tropomyosin messages by using heterologous primers (to consened regions)
derived from the rat skeletal muscle a-tropomyosin sequence.
The frog and zebrafash sequences are used in an analysis of
tropomyosin evolution across the vertebrate phylogenetic spectrum. The results underscore the consenative nature of the
tropomyosin molecule and support the notion of a constrained
heptapeptideunit as the fundamentalstructuralmotifof tropomyosin.
The polymerase chain reaction (PCR) is a powerful method
for the enrichment of specific target sequences. By carrying
out repeated cycles of annealing, synthesis, and denaturation
in the presence of a thermostable DNA polymerase [Thermus
aquaticus DNA polymerase (Taq polymerase)], sequences
bounded by a pair of short, sequence-specific primers can be
amplified more than a millionfold (1). However, the dependence of the PCR technique on a pair of specific primers
flanking the region of interest has generally limited its use to
targets whose sequence is known a priori.
Frequently, one is interested in sequences that have not
been as yet fully characterized. A method requiring only a
single small region of known sequence (from which specific
primers can be designed) while still taking advantage of the
power of PCR would substantially facilitate the extraction
and sequencing of DNA molecules.
We report here a general method for the amplification of
previously unsequenced cDNA target molecules. Fig. la
illustrates schematically the three-pronged approach we have
developed. First, we gain access into a transcript by isolating
and amplifying a core region, using two primers derived from
related sequences. Then, based on this core sequence, we
design primers that, in combination with a second nonspecific
primer [complementary either to the 3' poly(A) tail or to an

enzymatically synthesized tail at the 5' end], permit the
amplification of the regions both upstream and downstream
of the core sequence. The combination of a single specific
primer and a nonspecific primer generally is not sufficient to
yield a unique product. Consequently, we reamplify this mix
using a second specific primer, adjacent to the first, and the
same nonspecific primer. This results in the amplification of
a unique sequence.
These amplified fragments can be cloned into vectors from
which the insert can be subsequently sequenced (2); alternatively, they can be directly sequenced by using either the
"genomic sequencing" (3) or the dideoxy chain-termination
method (4). We have also used a rapid, direct, chemical
sequencing strategy that capitalizes on the specificity of the
PCR method. A single primer is labeled by using any of the
currently available tagging methods (see Materials and Methods) and then used to reamplify a sample previously enriched
for a particular sequence. This produces double-stranded
target molecules, labeled exclusively at one of the 5' ends,
that then can be chemically sequenced (5, 6) and visualized
directly on a sequencing gel.
To illustrate the power of these techniques, we extracted
(in parallel) and sequenced the complete transcripts of skeletal muscle a-tropomyosin from both the European common
frog (Rana temporaria) and the zebrafish (Brachydanio re-

rio).
Other methods that seek to extend the use of PCR to
previously unknown sequences have recently been reported.
The restriction digestion and subsequent circularization of
genomic DNA (inverse polymerase chain reaction, IPCR)
permits the amplification of unique sequences (7). Methods
involving the tailing of cDNA [the "RACE" (8) and "APCR" (9) approaches] permit the subsequent cloning of
uncharacterized or variable messages.

MATERIALS AND METHODS
Preparation of cDNA. Poly(A)+ RNA was prepared from
frog leg muscle and from complete zebrafish according to
standard methods (10). Poly(A)+ RNA was primed by using
an oligo(dT) 20-mer. cDNA synthesis on 100 ng of poly(Ar
RNA was accomplished by using Moloney murine leukemia
virus (Mo-MLV) reverse transcriptase in a volume of 5 µ.1
(11).
Amplificationof Core Region. Following cDNA synthesis
as described above, 100 pmol of each of a pair of specific
(imperfect) oligomers was added, in water, bringing the
volume to 75 µ.I. The mixture was boiled for 3 min and
quenched on ice. Remaining PCR reagents were then added.
Amplifications were done in 100 µ.l of 50 mM KCl, 10 mM
Tris·HCl (pH 8.8), 1.5 mM MgClz, 3 mM dithiothreitol, 0.1 mg
of bovine serum albumin per ml, 200 µ.M (each) dNTPs, and
Abbreviations: PCR, polymerase chain reaction; Mo-MLV, Moloney murine leukemia virus.
*Present address: Shionogi Research Laboratories, Fukushima-ku,
Osaka 553, Japan.
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first. PCR conditions were as follows: 55°C, 30 sec; 72°C, 1
min; 94°C, 40 sec; 30 cycles.
Direct Sequencingof PCR Products. Ten picomoles of a
specific PCR primer was labeled with T4 polynucleotide
kinase (NEB) and 200 µ,Ciof[y- 32P]ATP (6000 Ci/mmol; 1 Ci
= 37 GBq) under conditions specified by the supplier (37°C
for 30 min). The 10-µ,lkinase mixture was placed directly into
90 µ,l of standard PCR mixture containing 100 pmol of
unlabeled second primer and 1 ng of template DNA. Five to
10 PCR cycles generate enough labeled DNA for direct
chemical sequencing. Labeled fragment was gel purified in a
5% native acrylamide gel and recovered by absorbing onto a
DEAE membrane (13).

2.5 units of Taq polymerase. Thirty cycles of PCR were
carried out: annealing at 45°C, 2 min; extension at 72°C, 3
min; denaturation at 94°C, 1 min; final extension, 5 min.
AmpUficationof 3' Region. The amplifications for the 3'
region were carried out in a final 100-µ,lvolume, using a 10-µ,l
sample of the above "core amplification" mixture, to which
100 pmol of both a nested specific primer and the nonspecific
(d'fh 0 primer were added. Remaining reagents and PCR
conditions are as above.
Synthesisof SpecificcDNAMoleculesfor Amplificationof 5'
Region. A specific oligomer was used to prime the Mo-MLV
reverse transcriptase on the poly(A)+ RNA. Initial annealing
of the oligomer (1 fmol) was done in 5 µ,l containing 0.2 M
NaCl, 40 mM Tris·HCl (pH 7.5), 5 mM EDTA, and 100 ng of
poly(A)+ RNA, incubated at 65°C for 5 min, placed at 40°C
for 4 hr, ethanol precipitated, resuspended in 25 µ,l of reverse
transcriptase mix containing 50 mM Tris·HCl (pH 8.3), 75
mM KCl, 10 mM dithiothreitol, 3 mM MgC(z, 50 µ,g of
Actinomycin D per ml, 0.5 mM (each) dNTPs, and 200 units
of Mo-MLV reverse transcriptase (BRL), and incubated at
37°C for 1 hr.
Poly[d(A)]Tailing of SpecificcDNA Moleculesand Amplification of 5' Region. Following the synthesis described
above, the mixture was phenol extracted, ethanol precipitated twice, dried under vacuum, resuspended in 6.5 µ,l of
water, boiled for 2 min, quenched on ice, and tailed in a final
10-µ,l volume using terminal deoxynucleotidyltransferase,
according to standard protocols (12). The products were
ethanol precipitated and resuspended in 100 µ,l of the PCR
mixture as described in "Amplification of Core Region."
PCR conditions were as follows: 40 cycles, annealing at 50°C,
30 sec; extension at 72°C, 1 min; denaturation at 94°C for 40
sec, in the presence of 100 pmol of the specific oligomer and
(dT)i0 • A 10-µ,lsample of the above was reamplified in 100-µ,l
final volume with a nested, specific oligomer, internal to the

RESULTS
The results of our three-pronged approach (Fig. la) are
described below.
Sequencing the Core Region: Use of Imperfect Primers
Derivedfrom HomologousSequences.To enter the sequence
of the unknown tropomyosin cDNAs, we first identified
regions of high amino acid sequence conservation in previously sequenced tropomyosin genes (14-18). We chose primers complementary to those conserved stretches that contained amino acids· with low codon degeneracy and synthesized two sets of"21-mers," Rl/R2 and R3/R4, derived from
the rat tropomyosin nucleotide sequence (15, 16). Fig. lb
depicts the positions of all primers used in this study, and
Table 1 collects the sequences of all the oligonucleotides
described in this paper.
We prepared poly(A) + RNA from frog leg muscle and from
a complete zebrafish homogenate. Tropomyosin transcripts
appear to comprise >0.1 % of the total muscle poly(A) + RNA
pool (19). A complete array of cDNA molecules was then
generated from the poly(Ar RNA mixture using Mo-MLV

a

ss cDNA Synthesis
[(dT)20 primer]

ss cDNA Synthesis
[primed with R2]

Addition of dA Tail

1st PCR with (dT)20 and R3
2nd PCR with (dT)20 and Fr1

1st PCR with (dT)20 and R2
2nd PCR with (dT)20 and Fr2

Size Selection
(Agarose Gel)
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(Agarose Gel)

Design of new specific primers
(Fr1 and Fr2)
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F10. 1. Three-part strategy for cDNA amplification. (a) Steps involved in the amplification and eventual sequencing of complete cDN A
transcripts. ss, Single-stranded; TM, tropomyosin. (b) Position on an idealized tropomyosin
cDNA sequence of the various oligomers discussed in the text.
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Table 1. Oligonucleotide primer sequences
Rl:
R2:
R3:
R4:

FRI:
FR2:
FR3:
FR4:

PCR primer
5' -ATGGACGCCATCAAGAAGAAG-3' (1)
5'-CTCCATCTTCTCCTCATCCTT-3' (425)
5' -ATCCAGCTGGTTGAGGAGGAG-3' (273)
5'-GGTCTCAGCCTCCTTCAGCTT-3' (710)
5'-GAGCTTGAGGAAGAGTTGAAAA-3' (573)
5'-GTTCTCAATGACTTTCATGCCTC-3' (395)
Sequencing/probing primer
5'-CTGTTCTGCTCTGTCCAAGG-3' (71)
5'-TATGCCCAGAAACTGAAGTA-3' (780)

The prefixes indicate the source of the sequence information (R =
rat; FR = frog). Numbers in parentheses at the right indicate
nucleotide position on the target sequence where the 5' end of the
oligomer will anneal. Position 1 is the first nucleotide in the initiation
methionine.

reverse transcriptase (11) primed with an oligo(dT) 20-mer.
The single-stranded cDNA resulting from this synthesis
became the template for PCR amplifications using the two
sets of imperfect primers. As shown in Fig. lb, these imperfect primer pairs each spanned ==400nucleotides, with a
100-nucleotide region of overlap. Thus we sought to amplify
==700nucleotides of the tropomyosin transcript core region.
The results of the amplifications on frog and zebrafish
cDNA are shown in the left panel (lanes 1-4) of Fig. 2a.
Although a major discrete band of the expected size appears,
there might have been two or more isotypes of tropomyosin
present in the original cDNA preparations, and the amplified
product might have contained a mixture of different tropomyosin transcripts. To ensure that a homogeneous transcript
was sequenced, the amplified products were cut out of the 2%
agarose gel, eluted, and cloned into the "Bluescript" plasmid
vector (Stratagene) using the G-C tailing method (12). We
sequenced six colonies (20, 21) containing frog muscle cDNA
amplified with the R3/R4 primer pair: all were identical and
contained only the skeletal muscle a transcript. In contrast,
five colonies derived from the amplification of zebrafish
cDNA with the R3/R4 primer pair proved heterogeneous
upon sequencing: three colonies carried skeletal muscle a
transcripts, one carried smooth muscle ~ transcript, and one
contained the skeletal muscle ~ transcript. Since our focus
was exclusively on the major isotype oftropomyosin, and we
favor methods that do not involve the cloning and sequencing
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of a single amplified molecule, given concerns about the
fidelity ofTaq polymerase (22), we used direct sequencing of
the PCR product as frequently as possible. We obtained the
complete sequence of the core region directly from the
amplified fragments by using a combination of genomic
sequencing and the direct PCR-mediated sequencing method.
Even in those cases in which a mixture of templates was
present, the direct method allowed us to read the sequence of
the major cDNA isotype. Fig. 3 shows a representative
fragment of a sequencing gel obtained by this method.
Approximately 700 nucleotides of sequence were thus generated from each of the two tropomyosin cDNA sequences.
Nonetheless, substantial portions of the transcript, both
upstream and downstream of the amplified fragments, remained to be explored.
Characterizing the 3' Region: Enrichment Amplification
UsingOne-SidedSpecificPrimers. To extend our analysis into
the 3' region of the transcript, we amplified the cDNA
mixture prepared for the previous step, using equimolar
amounts of the single specific primer R3 (originally thought
to be imperfectly matched) located in the previously derived
core region, and the (dTho primer. After 30 cycles of amplification, a large number of different sequences appeared, as
shown by the smears in lanes 5 and 8 of Fig. 2a. This amplified
mixture nevertheless did include the sequence of interestthe 3' region of the tropomyosin transcript-since we could
detect it on a Southern blot by probing with an internal
oligomer (Fr4) (lanes 5 and 8, Fig. 2b).
To rescue the appropriate sequence, a 10% aliquot of the
above amplification was reamplified directly, using 100 pmol
of a new, nested specific oligomer (Frl) and an equimolar
amount of the (dTho oligomer. Lanes 6 and 9 of Fig. 2a (and
lanes 6 and 9, Fig. 2b) show that there is still a heterogeneous
mixture of amplified fragments, most likely reflecting the
distribution of poly(A)+ tail lengths. The uppermost band on
the 2% agarose gel (==400-500 nucleotides long), which
appeared to contain our target molecule, was cut out, eluted,
and reamplified using the same pair of primers [(dTho and
Frl]. This size-selection reduced the potential targets for
amplification and increased the specificity of subsequent
PCR rounds. Lanes 7 and 10, Fig. 2a, show that this resulted
in a single band, which contained the desired sequence (as
seen in lanes 7 and 10, Fig. 2b, probed with oligo Fr4). We
sequenced the amplified product using both the genomic

b
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1103
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396
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281,271
234
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FIG. 2. (a) Agarose gels stained with ethidium bromide showing the results of amplifications of core, 3', and 5' regions. Lanes Ml and M2,
DNA size markers (given in nucleotides) (t/,X Hae Ill digest and Bluescript Hinfl digest). Lanes 1-4, results of core region amplification: frog
cDNA, primers Rl/R2 (lane l); primers R3/R4 (lane 2); fish cDNA, primers Rl/R2 (lane 3); primers R3/R4 (lane 4). Lanes 5-10, 3' end
amplifications: frog cDNA, primers (dTh 0 /R3 (lane 5); primers (dT)20/Frl (lane 6); size-selected frog amplification, primers (dT) 20 /Frl (lane
7); fish cDNA, primers (dT)20/R3 (lane 8); primers (dT)20/Frl (lane 9); size-selected fish amplification, primers (dT) 20/Frl (lane 10). Lanes 11-16,
5' end amplifications: frog cDNA, primers (dn 20/R2 (lane 11); primers (dT)20/Fr2 (lane 12); size-selected frog amplification, primers (dTh 0 /Fr2
(lane 13); fish cDNA, primers (dT)20/R2 (lane 14); primers (dn 20/Fr2 (lane 15); size-selected fish amplification, primers (dTh 0 /Fr2 (lane 16).
(b) Southern blot of lanes 5-10, probed with oligomer Fr4. (c) Southern blot of lanes 11-16, probed with oligomer Fr3.
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Table 2. Summary of zebrafish (B. rerio) and European common
frog (R. temporaria) tropomyosin cDNA sequences
and comparisons

5' untranslated
B. rerio

R. temporaria
No. of nucleotide
differences

% difference

GAATCT
+

V

+

G C C
FIG. 3. Fragment of sequencing gel obtained by direct PCRmediated method. The fragment shown corresponds to the internal
core region of zebrafish tropomyosin cDNA (nucleotide positions
340-400). Sequencing reactions are as described in refs. 5 and 6.

sequencing and the direct sequencing methods previously
described. In this way, we generated an additional 300
nucleotides [including about 100 residues of the poly(A) tail]
in the case of the European common frog cDNA and =350
nucleotides of zebrafish tropomyosin sequence.
Characterizing the 5' Region: Single Primer Extension,
Tailing, and Amplification. By using a specific oligomer (R2)

complementary to the rat tropomyosin sequence, we primed
the Mo-MLVreverse transcriptase on the poly(A)+ RNA to
generate cDNA molecules containing the 5' region of the
transcript. We added poly(dA) tails using terminal deoxynucleotidyltransferase (12) and amplified these sequences by
PCR, using the same specific primer (R2) and a (dTho
nonspecific primer complementary to the newly added tails.
After 40 cycles of amplification, the PCR product could
generally not be visualized with ethidium bromide staining
(lanes 11 and 14, Fig. 2a) but did appear as a faint band on
subsequent Southern blots probed with an internal probe
(Fr3) (lanes 11 and 14, Fig. 2c; not visible in the reproduction). An aliquot of the above mixture, when reamplified with
a new, nested internal primer (Fr2) and the nonspecific (dTho
primer, resulted in a discrete band. This band, however, was
accompanied by a high molecular weight background (lanes
12 and 15, Fig. 2a; lanes 12 and 15, Fig. 2c). We cut out the
discrete band and reamplified using the same primer pair
[Fr2/(dTh 0]. In each case, this procedure yielded a major
band, which Southern blotting (lanes 13 and 16 in Fig. 2c)
and subsequent sequencing confirmed corresponds to the
5' regions of the frog and zebrafish tropomyosin cDNAs,
respectively.
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DISCUSSION
Our two cDNA sequences permit a comparison of tropomyosin sequences across the deepest of vertebrate phylogenetic
forks and substantially increase the time scale over which the
evolution of tropomyosin can be surveyed. The comparison
reveals an extremely stable and conservative structural protein. [The tropomyosin cDNA sequences have been deposited in GenBank (accession nos. M24634and M24635).Table
2 summarizes some properties of the sequences.] Despite the
broad phylogenetic distance ( =400 million years since the last
common ancestor) separating R. temporaria from B. rerio,
the two tropomyosin proteins differ at only 19 of 284 amino

3' untranslated

region

Coding region

region

87 nt
109 nt

855 nt (284 aa)
855 nt (284 aa)

75 nt
72 nt

*

130 nt
Silent: 101 nt
Replace: 29 nt
(18 aa)
Silent: 35
Replace: 3.2+

54 ntt

75.0

nt, Nucleotides; aa, amino acids.
*The 5' untranslated region shows two regions of sequence conservation [positions -109 to - 74 (frog), -87 to -52 (fish), and -6 to
1 (frog and fish)].
tThe 3' regions have been aligned without gaps.
+Percentage differences have been calculated according to ref. 23.
Shown are the weighted uncorrected averages. Corrected weighted
averages for silent positions = 110.5%; for replacement positions =
3.8%.

acids. This degree of conservation is probably due to the
structural role this protein plays, interacting with other
proteins (actin, troponin) in the muscle contraction apparatus
(24, 25).
A large number of different tropomyosins have been identified, from both muscle and cytoplasmic sources. Muscle
tissue (smooth and striated) may contain both a and {3
subunits of tropomyosin; up to nine isoforms of a given
tropomyosin may be present as a result of alternative splicing
(14, 26). This heterogeneity of possible tropomyosin forms
will be reflected in a mixture of cDNAs within a single
organism. A procedure such as ours, which used whole
organisms (in the case of zebrafish) or striated muscle (in the
case of the frog) to prepare mRNA, makes it difficult a priori
to determine which cDNA is being isolated. To determine the
identity of the cDNA sequences, we compared them to all
available vertebrate tropomyosin sequences: quail (Coturnix
coturnix) skeletal a-tropomyosin (27), chicken (Gallus gal/us) smooth muscle a-tropomyosin (28), rabbit (Oryctolaqus
cuniculus) muscle a-tropomyosin (29), rat (Rattus norvegicus) skeletal a- and {3-tropomyosins (15, 30), and human
(Homo sapiens) skeletal muscle a-tropomyosin and nonmuscle tropomyosin (31). Despite the extensive conservation in
the primary structure of this protein, interspecific variation in
the amino acid sequence does exist. A number of these
variable sites are diagnostic for particular tropomyosin types,
occurring (for example) in all striated muscle a-tropomyosins
but not in smooth muscle or {3-tropomyosins. Of the 86
variable sites in our comparison, 32 are possibly "informative" -a residue at that site is shared by at least two but no
more than n - 1 sequences in the comparison. The 12 sites
that are informative for this case all suggest that the two
cDNA sequences presented here are striated muscle atropomyosin messages.
Table 3 compares the striated-muscle a-tropomyosins from
five vertebrates (human, rat, quail, frog, and zebrafish). All
of these sequences are remarkably similar. Does the structural motif in tropomyosin-the putative NxxNAxB heptaresidue repeat that runs throughout the sequence associated with the double coiled-coil structure of the molecule
(33)-constrain this variation? In the five proteins compared,
there are 52 variable sites; of these, 29 are at "x" positions
within the hepatapeptide motif, whereas 11 occur at "N"
(hydrophobic) positions, 2 at" A" (acidic) positions, and 5 at
"B" (basic) positions. This distribution is significantly different from the uniform random expectation (P < 0.05), with
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Table 3. Amino acid sequence divergence of available skeletal
muscle a-tropomyosins
Zebrafish
Zebrafish
Frog
Quail
Rat
Human

10 (6.6)
12 (7.9)
14 (9.2)
10 (6.6)

Frog

Quail

Rat

Human

20 (7.0)

19 (6.7)
13 (4.6)

22 (7.7)
16 (5.6)
12 (4.2)

20 (7.0)
18 (6.3)
19 (6.7)
25 (8.8)

6 (3.9)
10 (6.6)
7 (4.6)

7 (4.6)
8 (5.3)

13 (8.6)

Figures above the diagonal indicate amino acid differences over
the entire molecule; figures in parentheses show the percentage
divergence between sequences. Data below the diagonal reflect
amino acid changes and percentage divergence after excluding the
most variable and alternatively spliced exons [l, 2, 6, and 9 (32)).
Percentages below the diagonal are calculated by using exons 3, 4,
5, 7, and 8 (total amino acids: 152).

an excess of substitutions at "x" positions that accords with
the prediction based on the heptapeptide motif: th~ second,
third, and fifth positions are less stringently constrained.
Nonetheless, the small amount of variation in these sequences reflects a strong purifying selection acting on practically every residue-in the overwhelming majority of positions even equivalent substitutions have been weeded out.
The 52 variant amino acids in our comparison occur at 38
positions; 47 of these changes are equivalent substitutions.
Curiously, the pattern of values in Table 3 is not what one
expects for a slowly evolving gene. The sequence divergences are not congruent with the phylogenetic tree based on
the species involved. (For example, the divergence between
rat and human tropomyosins is greater than the divergence
between frog and human tropomyosins.) This suggests
strongly that there are several genes for the skeletal muscle
a-tropomyosins, which diverged from a common ancestral
gene prior to the vertebrate colonization of the land. This
possibility is further supported by the distribution of parallel
substitutions at identical positions. At 10 variable positions
the same amino acid change occurs in two sequences, and in
no case does the similarity reflect common ancestry.
We believe this method for obtaining and characterizing
RNA transcripts represents a significant improvement over
previous approaches and holds great promise for the comparative sequencing of homologous transcripts from different
species. Initial entry into the cDNA sequence can be
achieved by using imperfect oligomers derived from related
organisms. The need for specific primers from only one side
of the region to be amplified expands the power of PCR,
permitting the amplification of previously uncharacterized
messages. This method does not require library construction
and screening, laborious and often unpredictable steps in the
isolation of complete transcripts, and, in contrast with previous approaches, requires a far smaller amount of starting
poly(A)+ RNA-only 300 ng of poly(Ar RNA was utilized
in determining the full sequences of both frog and zebrafish
tropomyosin cDNAs. Finally, the method lends itself to the
processing in parallel of cDNAs derived from a variety of
different sources.
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